Fund detail
Sands Capital Management
large-active, growth, lo
Quarters
52
2021-06-30
$58.98B
Positions
77
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TAYSHA GENE THERAPIES INC TSHA | $15.4M | 0.03% | 724,873 | +0 | +0.00% | 0.03% | 2020-09-30 | $21 | ~$22 | -1.48% | |
| 2 | 908 DEVICES INC MASS | $12.6M | 0.02% | 326,427 | +0 | +0.00% | 0.03% | 2020-12-31 | $39 | ~$57 | -31.96% | |
| 3 | SPRUCE BIOSCIENCES INC | $8.8M | 0.01% | 787,007 | +0 | +0.00% | 0.03% | 2020-12-31 | $11 | ~$24 | -53.89% | |
| 4 | TARSUS PHARMACEUTICALS INC TARS | $7.5M | 0.01% | 260,000 | +0 | +0.00% | 0.02% | 2020-12-31 | $29 | ~$41 | -29.88% |